Answers are grounded in this paper and cite their sources.
B cell depleting anti-CD20 monoclonal antibodies (aCD20 mAbs) are highly effective in treatment of multiple sclerosis (MS) but fail to halt the formation of meningeal ectopic lymphoid tissue (mELT) in the murine model experimental autoimmune encephalomyelitis (EAE). While mELT can be examined in EAE, it is not accessible
No takes yet. Share an insight, caveat, or question.
Georgieva et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: